Menu

The Herbert Irving Comprehensive Cancer Center is located at New York City’s Columbia University, one of the most respected institutions in the United States. It is one of two cancer centers run by the NewYork-Presbyterian Medical Center, a large medical facility associated with the university. Herbert Irving’s “parent” medical center, NewYork-Presbyterian Medical Center, was formed in 1998 when two historic New York City hospitals – New York Hospital and Presbyterian Hospital – merged into one. That merger formed the largest and most comprehensive medical facility in all of New York State.

Columbia University’s foray into cancer research came more than a century ago when, in 1911, the university launched its first Institute for Cancer Research. The birth of the Herbert Irving Comprehensive Cancer Center came in 1972, when the center received funding from the U.S. government’s National Cancer Institute (NCI); it was designated as a comprehensive cancer center in 1979 and remains one of just 41 NCI-designated comprehensive cancer centers in the United States. Just three of those are located in New York State.

The Herbert Irving Comprehensive Cancer Center(HICCC) features the Columbia University Mesothelioma Center to treat patients with pleural mesothelioma cancer. The Center uses a multidisciplinary approach to treat patients and offers expert care from many departments and specialities. The physicians at the center are constantly performing clinical trials to advance treatment options for patients, with one recent trial analyzes the efficacy of pre- and post-operative chemotherapy and radiation treatment for pleural mesothelioma. Other experimental treatments the center offers includes vaccine therapy and in vitro chemosensitivity testing.

The center has the ability to offer these cutting edge treatments after receiving over $95 million in cancer research grants. The research conducted at the HICCC is split into three divisions: basic, disease-specific and population-based research, enabling further specialization by researchers. All the research conducted at the HICCC is in the hopes of cancer prevention and improving quality of life for patients battling the disease.

Specializations:

  • Chemotherapy
  • Clinical trials
  • In vitro chemosensitivity testing
  • Pleural mesothelioma
  • Radiation
  • Thoracic surgery
  • Vaccine therapy

Accreditations:

  • NCI Center of Excellence in Mesothelioma
  • NCI Community Oncology Research Program
  • NCI Comprehensive Cancer Center
  • U.S. News & World Report Best Hospital Cancer

Mesothelioma Clinical Trials at Herbert Irving Comprehensive Cancer Center

The following clinical trials are in progress or actively recruiting participants at Herbert Irving Comprehensive Cancer Center:

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors


Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Renal Cell, Mesothelioma, Breast Neoplasms, Lung Neoplasms, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Endometrial Neoplasms, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma, Anus Neoplasms

Last Updated: April 29, 2019

Status: Recruiting

Sorry, there are no clinical trials to display

Photo of Herbert Irving Comprehensive Cancer Center

Get Help Contacting Herbert Irving Comprehensive Cancer Center


    Privacy policy: All information is secure and will never be released

    TRUSTe

    Free

    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide



      Privacy policy: All information is secure and will never be released

      TRUSTe